Make the CRISPR Call With This Genomics ETF

Investors looking for access to CRISPR gene editing technologies should consider the ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG), one of the ETFs best-positioned in this fast growing arena. Looking ahead, CRISPR-based innovations to accelerate given the technology’s ease of use,...